Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Essity AB (publ) (ESSITY-B.ST)
Stockholm, AB, SE
Essity AB (publ) is a global manufacturer and distributor of personal care and wellness goods, along with related services. Its portfolio encompasses medical and healthcare items such as incontinence management solutions, wound care treatments, compression wear, orthopedic supports, skincare formulations, and advanced digital health tools featuring sensor technology. The company organizes its business into several divisions: Personal Care, Consumer Tissue, Professional Hygiene, and various other operations. Essity also manufactures a wide array of consumer products, including absorbent items (pads, diapers, washable absorbent underwear, menstrual cups, incontinence products), personal care items (wet wipes, skincare, intimate soaps), and paper goods (toilet papers, household towels, handkerchiefs, facial tissues, napkins). For professional settings, its hygiene offerings include restroom essentials (toilet papers, paper hand towels, napkins), hand care (soaps, lotions, sanitizers), dispensing systems, and cleaning/wiping solutions. Furthermore, the firm delivers digital innovations, particularly Internet of Things (IoT) sensor technology designed for data-driven facility management, alongside associated service and maintenance. These solutions cater to a diverse clientele, including corporate offices, educational institutions, healthcare providers, industrial sites, food service establishments, hospitality venues, sports arenas, and various other public spaces. Its medical and healthcare product lines, sold under brand names such as TENA, Leukoplast, Cutimed, JOBST, Actimove, and Delta-Cast, reach consumers through a variety of channels, including pharmacies, specialized medical device retailers, hospitals, authorized distributors, care facilities, and online platforms. Consumer products, featuring brands like Libero, Libresse, Nosotras, Saba, TOM Organic, Lotus, Regio, Tempo, and Vinda, are available via retail outlets and e-commerce. Professional hygiene items, branded as TORK, are distributed through intermediaries and digital storefronts. Essity's market presence extends across Europe, North America, Latin America, Asia, and other international regions. Established in 1849, Essity AB (publ) maintains its headquarters in Stockholm, Sweden.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.15% | +0.50% | +6.18% | -9.64% | -0.61% | -0.92% | -7.38% | -10.27% | -9.36% | +4.47% | +4.47% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 5 | 0 |
| Hold | 6 | -2 |
| Sell | 1 | 0 |
| Strong Sell | 2 | 0 |
-
Revenue growth Household & Personal Products: +3.3%-4.9% Q1'26: -5.1% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%-38.4% Q1'26: -4.5% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+8.1% Q1'26: +9.0% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+13.4% ★ Q1'26: +13.2% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+12.0% ★ Q1'26: +10.9% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%-1.6% ★ Q1'26: -1.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×1.50× Q1'26: 1.73× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 14 Rev. Ana. 13 EPS Ana. |
Dec 2027 14 Rev. Ana. 13 EPS Ana. |
Dec 2028 11 Rev. Ana. 10 EPS Ana. |
Dec 2029 5 Rev. Ana. 4 EPS Ana. |
Dec 2030 5 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
109.27B
est: 109.27B (0.0%)
|
118.50B
est: 117.83B (+0.6%)
|
128.98B
est: 128.45B (+0.4%)
|
121.75B
est: 121.00B (+0.6%)
|
121.87B
est: 120.96B (+0.8%)
|
156.17B
est: 156.12B (+0.0%)
|
147.15B
est: 145.18B (+1.4%)
|
145.55B
est: 145.61B (0.0%)
|
138.49B
est: 138.95B (-0.3%)
|
139.49B
136.35B – 143.88B
+0.4% YoY
|
144.11B
139.98B – 148.18B
+3.3% YoY
|
147.77B
147.58B – 147.95B
+2.5% YoY
|
150.50B
146.64B – 154.99B
+1.8% YoY
|
153.60B
149.67B – 158.18B
+2.1% YoY
|
| EBITDA |
18.14B
est: 17.32B (+4.7%)
|
17.64B
est: 18.68B (-5.6%)
|
22.60B
est: 20.37B (+11.0%)
|
24.89B
est: 19.19B (+29.7%)
|
20.46B
est: 19.18B (+6.7%)
|
15.44B
est: 24.75B (-37.6%)
|
20.90B
est: 34.84B (-40.0%)
|
26.14B
est: 34.94B (-25.2%)
|
25.74B
est: 33.34B (-22.8%)
|
33.47B
32.72B – 34.52B
+0.4% YoY
|
34.58B
33.59B – 35.55B
+3.3% YoY
|
35.46B
35.41B – 35.50B
+2.5% YoY
|
36.11B
35.19B – 37.19B
+1.8% YoY
|
36.85B
35.91B – 37.95B
+2.1% YoY
|
| EBIT |
11.86B
est: 11.44B (+3.6%)
|
10.78B
est: 12.34B (-12.6%)
|
14.39B
est: 13.45B (+7.0%)
|
16.79B
est: 12.67B (+32.5%)
|
13.28B
est: 12.66B (+4.8%)
|
8.60B
est: 16.35B (-47.4%)
|
13.77B
est: 27.84B (-50.5%)
|
18.63B
est: 27.92B (-33.3%)
|
18.58B
est: 26.65B (-30.3%)
|
26.75B
26.15B – 27.59B
+0.4% YoY
|
27.64B
26.85B – 28.42B
+3.3% YoY
|
28.34B
28.30B – 28.37B
+2.5% YoY
|
28.86B
28.12B – 29.72B
+1.8% YoY
|
29.46B
28.70B – 30.34B
+2.1% YoY
|
| Net Income |
8.12B
est: 8.31B (-2.3%)
|
7.89B
est: 7.74B (+1.9%)
|
9.22B
est: 10.39B (-11.3%)
|
10.23B
est: 10.70B (-4.4%)
|
8.62B
est: 8.67B (-0.5%)
|
5.57B
est: 7.72B (-27.9%)
|
9.55B
est: 9.98B (-4.2%)
|
20.89B
est: 13.34B (+56.6%)
|
12.66B
est: 13.14B (-3.7%)
|
12.10B
12.08B – 13.99B
-7.9% YoY
|
13.31B
12.71B – 15.44B
+10.0% YoY
|
14.19B
13.73B – 16.13B
+6.6% YoY
|
14.87B
14.38B – 15.45B
+4.8% YoY
|
15.71B
15.19B – 16.32B
+5.6% YoY
|
| SGA |
19.13B
est: 19.41B (-1.5%)
|
20.57B
est: 20.93B (-1.7%)
|
22.32B
est: 22.82B (-2.2%)
|
22.09B
est: 21.50B (+2.8%)
|
21.62B
est: 21.49B (+0.6%)
|
26.11B
est: 27.74B (-5.9%)
|
25.66B
est: 26.10B (-1.7%)
|
27.35B
est: 26.17B (+4.5%)
|
26.57B
est: 24.98B (+6.4%)
|
25.07B
24.51B – 25.86B
+0.4% YoY
|
25.90B
25.16B – 26.63B
+3.3% YoY
|
26.56B
26.53B – 26.59B
+2.5% YoY
|
27.05B
26.36B – 27.86B
+1.8% YoY
|
27.61B
26.90B – 28.43B
+2.1% YoY
|
| EPS |
11.56
est: 11.86 (-2.6%)
|
11.23
est: 11.05 (+1.6%)
|
13.12
est: 14.83 (-11.5%)
|
14.56
est: 15.29 (-4.7%)
|
12.27
est: 12.38 (-0.9%)
|
7.93
est: 11.03 (-28.1%)
|
13.60
est: 14.20 (-4.3%)
|
29.83
est: 19.31 (+54.5%)
|
18.37
est: 19.02 (-3.4%)
|
19.08
17.54 – 20.30
+0.3% YoY
|
20.58
18.45 – 22.41
+7.9% YoY
|
22.05
19.93 – 23.41
+7.1% YoY
|
21.58
20.86 – 22.42
-2.1% YoY
|
22.80
22.04 – 23.68
+5.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-28 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-27 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-26 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-25 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-22 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-21 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-20 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-19 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-18 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-15 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-13 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-12 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-05 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-04 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-29 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-27 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI Sweden ETF EWD | 2.24% | 11.44M | 0.51% |
| 2 | iShares MSCI Global Sustainable Development Goals ETF SDG | 2.20% | 3.73M | 0.50% |
| 3 | Invesco STOXX Europe 600 Optimised Personal & Household Goods UCITS ETF SC04.DE | 2.00% | 928.7K | 0.20% |
| 4 | iShares OMX Stockholm Capped UCITS ETF OM3X.DE | 1.91% | 4.10M | 0.10% |
| 5 | iShares STOXX Europe 600 Personal & Household Goods UCITS ETF (DE) EXH7.DE | 1.75% | 3.81M | 0.46% |
| 6 | iShares MSCI Europe Quality Dividend Advanced UCITS ETF EQDS.L | 1.40% | 13.31M | 0.28% |
| 7 | State Street SPDR MSCI Europe Consumer Staples UCITS ETF CSTP.L | 1.36% | 2.30M | 0.18% |
| 8 | iShares MSCI Europe Consumer Staples Sector UCITS ETF ESIS.L | 1.36% | 7.27M | 0.18% |
| 9 | Brandes International ETF BINV | 1.33% | 2.78M | 0.70% |
| 10 | Xtrackers MSCI Europe Consumer Staples Screened UCITS ETF 1C XS3R.L | 1.32% | 774.8K | 0.17% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ulrika Kolsrud | President & Chief Executive Officer | 23M | female |
| Carl Fredrik Stenson Rystedt Econ. | CFO, Executive VP of Central Function Finance | 16M | male |
| Jessica Alm | Chief Communication Officer & Central Function of Corporate Communications | — | female |
| Mikael Schmidt | CLO, General Counsel, Secretary of the Board & Central Function of Legal Affairs and Compliance | — | male |
| Niklas Westin Sundberg | Chief Digital & Information Officer | — | male |
| Pablo Fuentes | President of Business Unit Professional Hygiene | — | male |
| Sandra Åberg | Vice President & Head of Investor Relations | — | female |
| Tuomas Yrjölä | President of Business Unit Personal Care | — | male |
| Anna Sävinger-Åslund | Chief Human Resources Officer & Central Function Human Resources | — | female |
| Volker Zoller | President of Business Unit Consumer Tissue | — | male |
| Carl-Magnus Månsson | Chief Digital & Information Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ESSITY-B.ST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
